Genkyotex S.A
Genkyotex has become a wholly owned subsidiary of Calliditas and have been delisted from the Euronext stock exchanges. Genkyotex’s lead product candidate, setanaxib, is a first-in-class NOX inhibito...load more
Genkyotex S.A's Basic Information
Genkyotex S.A's Competitors
Employee Insights
Genkyotex S.A's Top Employees
Frequently Asked Questions Regarding Genkyotex S.A
Connect with anyone with AroundDeal today!
Whether you're looking to connect with key decision-makers or making remote or global hires, we've got you covered.
✔ GDPR aligned & CCPA compliant✔ Cancel anytime✔ 5 free contacts